Cargando…

Renal Morbidity Following Radical Cystectomy in Patients with Bladder Cancer

BACKGROUND: Patients with chronic kidney disease (CKD) are poor candidates for standard treatments for muscle-invasive bladder cancer (MIBC) and may be more likely to experience adverse outcomes when diagnosed with MIBC. OBJECTIVE: To investigate factors associated with the development of advanced C...

Descripción completa

Detalles Bibliográficos
Autores principales: Schmidt, Bogdana, Velaer, Kyla N., Thomas, I.-Chun, Ganesan, Calyani, Song, Shen, Pao, Alan C., Thong, Alan E., Liao, Joseph C., Chertow, Glenn M., Skinner, Eila C., Leppert, John T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8738897/
https://www.ncbi.nlm.nih.gov/pubmed/35024629
http://dx.doi.org/10.1016/j.euros.2021.11.001
_version_ 1784629002802036736
author Schmidt, Bogdana
Velaer, Kyla N.
Thomas, I.-Chun
Ganesan, Calyani
Song, Shen
Pao, Alan C.
Thong, Alan E.
Liao, Joseph C.
Chertow, Glenn M.
Skinner, Eila C.
Leppert, John T.
author_facet Schmidt, Bogdana
Velaer, Kyla N.
Thomas, I.-Chun
Ganesan, Calyani
Song, Shen
Pao, Alan C.
Thong, Alan E.
Liao, Joseph C.
Chertow, Glenn M.
Skinner, Eila C.
Leppert, John T.
author_sort Schmidt, Bogdana
collection PubMed
description BACKGROUND: Patients with chronic kidney disease (CKD) are poor candidates for standard treatments for muscle-invasive bladder cancer (MIBC) and may be more likely to experience adverse outcomes when diagnosed with MIBC. OBJECTIVE: To investigate factors associated with the development of advanced CKD following radical cystectomy. DESIGN, SETTING, AND PARTICIPANTS: Using national Veterans Health Administration utilization files, we identified 3360 patients who underwent radical cystectomy for MIBC between 2004 and 2018. OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: We examined factors associated with the development of advanced CKD (estimated glomerular filtration rate [eGFR] of <30 ml/min/1.73 m(2)) after radical cystectomy using multivariable logistic and proportional hazard regression, with and without consideration of competing risks. We examined survival using Kaplan-Meier product limit estimates and proportional hazard regression. RESULTS AND LIMITATIONS: The median age at surgery was 67 yr and the mean preoperative eGFR was 69.1 ± 20.3 ml/min/1.73 m(2). Approximately three out of ten patients (n = 962, 29%) progressed to advanced CKD within 12 mo. Older age (hazard ratio [HR] per 5-yr increase 1.15, 95% confidence interval [CI] 1.10–1.20), preoperative hydronephrosis (HR 1.50, 95% CI 1.29–1.76), adjuvant chemotherapy (HR 1.19, 95% CI 1.00–1.41), higher comorbidity index (HR 1.13, 95% CI 1.11–1.16 per point), and lower baseline kidney function (HR 0.75, 95% CI 0.73–0.78) were associated with the development of advanced CKD. Baseline kidney function at the time of surgery was associated with survival. Generalizability is limited due to the predominantly male cohort. CONCLUSIONS: Impaired kidney function at baseline is associated with progression to advanced CKD and mortality after radical cystectomy. Preoperative kidney function should be incorporated into risk stratification algorithms for patients undergoing radical cystectomy. PATIENT SUMMARY: Impaired kidney function at baseline is associated with progression to advanced chronic kidney disease and mortality after radical cystectomy.
format Online
Article
Text
id pubmed-8738897
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-87388972022-01-11 Renal Morbidity Following Radical Cystectomy in Patients with Bladder Cancer Schmidt, Bogdana Velaer, Kyla N. Thomas, I.-Chun Ganesan, Calyani Song, Shen Pao, Alan C. Thong, Alan E. Liao, Joseph C. Chertow, Glenn M. Skinner, Eila C. Leppert, John T. Eur Urol Open Sci Bladder Cancer BACKGROUND: Patients with chronic kidney disease (CKD) are poor candidates for standard treatments for muscle-invasive bladder cancer (MIBC) and may be more likely to experience adverse outcomes when diagnosed with MIBC. OBJECTIVE: To investigate factors associated with the development of advanced CKD following radical cystectomy. DESIGN, SETTING, AND PARTICIPANTS: Using national Veterans Health Administration utilization files, we identified 3360 patients who underwent radical cystectomy for MIBC between 2004 and 2018. OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: We examined factors associated with the development of advanced CKD (estimated glomerular filtration rate [eGFR] of <30 ml/min/1.73 m(2)) after radical cystectomy using multivariable logistic and proportional hazard regression, with and without consideration of competing risks. We examined survival using Kaplan-Meier product limit estimates and proportional hazard regression. RESULTS AND LIMITATIONS: The median age at surgery was 67 yr and the mean preoperative eGFR was 69.1 ± 20.3 ml/min/1.73 m(2). Approximately three out of ten patients (n = 962, 29%) progressed to advanced CKD within 12 mo. Older age (hazard ratio [HR] per 5-yr increase 1.15, 95% confidence interval [CI] 1.10–1.20), preoperative hydronephrosis (HR 1.50, 95% CI 1.29–1.76), adjuvant chemotherapy (HR 1.19, 95% CI 1.00–1.41), higher comorbidity index (HR 1.13, 95% CI 1.11–1.16 per point), and lower baseline kidney function (HR 0.75, 95% CI 0.73–0.78) were associated with the development of advanced CKD. Baseline kidney function at the time of surgery was associated with survival. Generalizability is limited due to the predominantly male cohort. CONCLUSIONS: Impaired kidney function at baseline is associated with progression to advanced CKD and mortality after radical cystectomy. Preoperative kidney function should be incorporated into risk stratification algorithms for patients undergoing radical cystectomy. PATIENT SUMMARY: Impaired kidney function at baseline is associated with progression to advanced chronic kidney disease and mortality after radical cystectomy. Elsevier 2022-01-03 /pmc/articles/PMC8738897/ /pubmed/35024629 http://dx.doi.org/10.1016/j.euros.2021.11.001 Text en © 2021 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Bladder Cancer
Schmidt, Bogdana
Velaer, Kyla N.
Thomas, I.-Chun
Ganesan, Calyani
Song, Shen
Pao, Alan C.
Thong, Alan E.
Liao, Joseph C.
Chertow, Glenn M.
Skinner, Eila C.
Leppert, John T.
Renal Morbidity Following Radical Cystectomy in Patients with Bladder Cancer
title Renal Morbidity Following Radical Cystectomy in Patients with Bladder Cancer
title_full Renal Morbidity Following Radical Cystectomy in Patients with Bladder Cancer
title_fullStr Renal Morbidity Following Radical Cystectomy in Patients with Bladder Cancer
title_full_unstemmed Renal Morbidity Following Radical Cystectomy in Patients with Bladder Cancer
title_short Renal Morbidity Following Radical Cystectomy in Patients with Bladder Cancer
title_sort renal morbidity following radical cystectomy in patients with bladder cancer
topic Bladder Cancer
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8738897/
https://www.ncbi.nlm.nih.gov/pubmed/35024629
http://dx.doi.org/10.1016/j.euros.2021.11.001
work_keys_str_mv AT schmidtbogdana renalmorbidityfollowingradicalcystectomyinpatientswithbladdercancer
AT velaerkylan renalmorbidityfollowingradicalcystectomyinpatientswithbladdercancer
AT thomasichun renalmorbidityfollowingradicalcystectomyinpatientswithbladdercancer
AT ganesancalyani renalmorbidityfollowingradicalcystectomyinpatientswithbladdercancer
AT songshen renalmorbidityfollowingradicalcystectomyinpatientswithbladdercancer
AT paoalanc renalmorbidityfollowingradicalcystectomyinpatientswithbladdercancer
AT thongalane renalmorbidityfollowingradicalcystectomyinpatientswithbladdercancer
AT liaojosephc renalmorbidityfollowingradicalcystectomyinpatientswithbladdercancer
AT chertowglennm renalmorbidityfollowingradicalcystectomyinpatientswithbladdercancer
AT skinnereilac renalmorbidityfollowingradicalcystectomyinpatientswithbladdercancer
AT leppertjohnt renalmorbidityfollowingradicalcystectomyinpatientswithbladdercancer